Semaglutide – 5mg

Semaglutide is a long acting synthetic GLP-1 receptor agonist with a half-life of approximately 7 days, achieved through fatty acid chain conjugation enabling albumin binding and protection against DPP-4 enzymatic degradation. iLab Pharma’s 5mg lyophilized vial sits between the existing 10mg iLab Pharma lyophilized vial and the pen format presentations in CSD’s Semaglutide range. Providing a mid range reconstitute vial option for researchers requiring less total compound than the 10mg vial supplies or greater dosing flexibility than the fixed and adjustable pen formats accommodate.

The 5mg lyophilized vial format serves a distinct research purpose within CSD’s Semaglutide vial range. The 10mg iLab Pharma vial suits extended protocols and multi group experimental designs requiring significant compound availability from a single source. The 5mg format targets shorter duration protocols, initial compound evaluation before committing to larger supply volumes, or research designs where precise low to mid range reconstitution concentration control is the priority variable. At 5mg total this vial provides half the compound per unit of the 10mg vial while maintaining the same reconstitute format advantages. Researcher controlled concentration preparation, in vitro research applicability, and parenteral administration flexibility that pen delivery systems cannot accommodate.

CSD’s Semaglutide range now spans six distinct presentations, the 2mg adjustable single pen, the 4mg adjustable pen in generic and F40 Biotech variants, the 9.6mg fixed dose prefilled pen, this 5mg iLab Pharma lyophilized vial, and the 10mg iLab Pharma lyophilized vial. Covering every Semaglutide concentration and format requirement across pen and vial delivery systems from a single verified Canadian supplier. The pure GLP-1 receptor selectivity of Semaglutide remains consistent across all presentations, maintaining its position as the single receptor reference standard against which CSD’s dual and triple incretin agonist listings are compared in comparative receptor pathway research.

iLab Pharma formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COC documentation available on request. CSD’s sourcing standards apply uniformly across all manufacturers we carry, and iLab Pharma’s Semaglutide 5mg meets those standards consistently. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.

Reconstitute with bacteriostatic water prior to use. Store lyophilized peptide at 2–8°C away from direct light. Once reconstituted refrigerate and use within 28 days. Intended for research purposes only.

Commonly researched alongside dual and triple incretin agonist compounds in comparative GLP-1 receptor pathway and metabolic activity studies. Browse CSD’s full peptide range for complete sourcing.